Drug Review

The evidence-informed decision-making process of the National Essential Medicines List Committee and Essential Drugs Programme

Amanda Brewer, Janine Jugathpal, Kim MacQuilkan, Marc Blockman, Andrew Gray, Tamara Kredo, Reneé de Waal, Lesley Robertson
Journal of the Colleges of Medicine of South Africa | Vol 4, No 1 | a369 | DOI: https://doi.org/10.4102/jcmsa.v4i1.369 | © 2026 Amanda Brewer, Janine Jugathpal, Kim MacQuilkan, Marc Blockman, Andrew Gray, Tamara Kredo, Reneé de Waal, Lesley Robertson | This work is licensed under CC Attribution 4.0
Submitted: 20 January 2026 | Published: 27 March 2026

About the author(s)

Amanda Brewer, Essential Drugs Programme, South African National Department of Health, Pretoria, South Africa
Janine Jugathpal, Essential Drugs Programme, South African National Department of Health, Pretoria, South Africa
Kim MacQuilkan, Essential Drugs Programme, South African National Department of Health, Pretoria, South Africa
Marc Blockman, Department of Medicine, Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa
Andrew Gray, Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa
Tamara Kredo, Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa
Reneé de Waal, Centre for Integrated Data and Epidemiological Research, School of Public Health, University of Cape Town, Cape Town, South Africa
Lesley Robertson, Department of Psychiatry, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa

Abstract

No abstract available.

Keywords

essential; standards; evidence-informed; health; technology; medicines; treatment; guidelines

Metrics

Total abstract views: 175
Total article views: 192


Crossref Citations

No related citations found.